3-(2,2,2-trimethylhydrazine)propionate has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cirule, H; Dambrova, M; Kigitovica, D; Korzh, S; Liepinsh, E; Makrecka-Kuka, M; Skride, A; Videja, M; Vilks, K; Vilskersts, R | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Protective Effects of Meldonium in Experimental Models of Cardiovascular Complications with a Potential Application in COVID-19.
Topics: Animals; Cardiotonic Agents; Cardiotoxicity; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Endothelium; Heart Failure; Heart Ventricles; Hydrogen Peroxide; Lung; Male; Methylhydrazines; Mice, Inbred C57BL; Mitochondria; Oxygen Saturation; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2021 |